Latest News
Eqtec Shares Edge Higher After Securing Funding for Its Italia MDC Plant From Its Partners
Shares of EQTEC PLC (LON: EQT) rallied higher after signing the final contract for the funding of its Italia MDC plant after its partners agreed to pay €2.1 million for an 80% stake in the project, with Eqtec owning the remaining 20%. The waste to

Remote Monitored Systems (RMS) Signs Agreement With PIC Consultants
Remote Monitored Systems (LON: RMS) shares are trading lower on Monday despite announcing it has signed a deal with PIC Consultants. The deal will see the company supply a new range of retail hydroponic nutrients for distribution into the UK hydro

Orphazyme (ORPH) Stock Plunges After Arimoclomol Setback
Shares of biopharmaceutical company Orphazyme (NASDAQ: ORPH) have plunged on Friday after it announced it has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) following its review of the new drug application fo

AnPac Bio Stock Rallies After Being Granted First Disease Treatment Patent and Securing Cancer Treatment Funding
Shares of AnPac Bio are trading higher premarket after the company announced it has been granted its first disease treatment patent by the United States Patent and Trademark Office and that its newly launched cancer treatment joint venture has secure

ReNeuron (RENE) Shares Rallied 8.2%, Completing Their Recovery From the Recent Crash
Shares of ReNeuron Group Plc (LON: RENE) rallied 8.2% to complete its recovery from the recent lows triggered by the suspension of the Phase 2a clinical trial dosing programme for its retinitis pigmentosa (RP) treatment. The company halted the dos

Mitsubishi HC Capital To Acquire CAI International (CAI), Stock Surges
CAI International's (NYSE: CAI) share price is rallying premarket on Friday after announcing that Mitsubishi HC Capital (MHC) will acquire the company for approximately $1.1 billion. The all-stock transaction will see MHC pay $56 per share for the

Braveheart Investment (BRH) Shares Climb As Profits Surge
Shares of Braveheart Investment (LON: BRH) are climbing after the company reported a profit for the year ended 31 March. The AIM-listed firm reported a pre-tax profit of £14.2 million after the company cashed in on Pharm 2 Farm and Remote Monitore

Dev Clever Shares Are Up 46.9% in June as Investors React to Its Progress in India
Shares of Dev Clever Holdings PLC (LON: DEV) are up 46.9% in June after releasing a progress update regarding its Indian operation following its exclusive partnership with the National Independent Schools Alliance (NIS

Challenger Energy (CEG) Shares Edged 3.82% Higher on Positive Drill Data at Saffron-2
Shares of Challenger Energy Group PLC (LON: CEG) edged 3.82% higher after releasing a positive update regarding the drilling operations at its Saffron-2 well in Trinidad and Tobago. According to the oil exploration and mining company, petrophysica

Vast Resources (VAST) Shares Edge Higher After Appointing Wardell Armstrong For Resource Verification
Vast Resources (LON: VAST) shares are up slightly on Friday after the company announced it has appointed Wardell Armstrong, a multidisciplinary environmental, engineering and mining consultancy, to work on the verification of the increased JORC Resou

Yourgene Health (YGEN) Wins DPYD Testing Kit Contract, Shares Down
Yourgene Health (LON: YGEN) announced on Friday that it has been awarded a contract to supply its Elucigene DPYD testing kits to NHS Wales. The Elucigene DPYD screens cancer patients before the start of treatment with chemotherapeutic drug 5-Fluor

Nanox Imaging Stock Rallies on FDA Submission for Multi-Source Nanox.ARC
Medical imaging technology firm Nanox Imaging (NASDAQ: NNOX) are rallying after the company announced it has submitted a 510(k) premarket notification application to the US Food and Drug Administration (FDA) for the first version of its multi-source

Midatech Pharma Shares Spiked 88.2% Higher After Unveiling Breakthrough Technology
The shares of Midatech Pharma spiked 88.2% higher after reporting that its Q-Sphera technology can formulate monoclonal antibodies into long-acting injectables. Investors cheer

Tiziana (TILS) Share Price Rallied 7.28% Bouncing off Support on UK Govt Grant Application
Shares of Tiziana Life Sciences PLC (LON: TILS) rallied 7.28% after announcing that it had applied for a UK government grant for its nasally-administered COVID-19 treatment known as Forulamab.Â

Cake Box (CBOX) Shares Fall After It Notifies Customers About Data Breach
Cake Box (LON: CBOX) shares are falling after the company said it has recently emailed customers concerning a data breach experienced in 2020, where personal and financial information may potentially have been accessed. The cake maker and retailer

DeepMatter (DMTR) Shares Edge Higher on Collaboration
DeepMatter announced on Thursday that it has been selected as a partner for the University of Leeds following a £1.4M EPSRC investment they received to develop automated precision manufacturing approaches in collaboration with the University of Sheff

Kodal Minerals (KOD) Share Rise As Dabakala Concession Demonstrates High-Grade Gold
Shares of Kodal Minerals (LON: KOD) are rising on Thursday after the company said the Dabakala Concession in the Ivory Coast has demonstrated a high-grade geochemical anomaly. Geochemical sampling continues to return high-grade surface samples at

Open Orphan (ORPH) Shares Fall 11% After Losses Widen
Shares of Open Orphan are falling after the company posted widened losses in 2020. The AIM-listed pharmaceutical company reported a loss of £10.79 million, nearly double the £5.7 million loss in 2019. Project and administrative costs contribute

Redx Pharma Shares Surged 7% on $4mln AstraZeneca Milestone Payment
Shares of Redx Pharma PLC (LON: REDX) surged 7% after announcing that it had qualified to receive the first milestone payment of $4 million from AstraZeneca, which licensed its RXC006 drug candidate targeted at treating fibrotic diseases. The biot

Aprea Therapeutics (APRE) Stock Jumps On Positive Leukaemia Trial Results
Aprea Therapeutics (NASDAQ: APRE) shares are rallying on Wednesday after the company said the Phase 1/2 trial evaluating the frontline treatment of eprenetapopt with venetoclax and azacitidine in patients with TP53
